SK Chemical challenges to develop tetravalency influenza vaccine

Published: 2014-02-12 06:56:00

Updated: 2014-02-12 06:56:00

(Yakup Shinmoon)

SK Chemical challenges to develop tetravalency influenza (flu) vaccine in preparation for potential pandemic flu virus mutations by the way of cell culture.

On Feb 7, SK Chemical announced that they received approval of clinical trial plan of tetravalency influenza vaccine by cell culture technology from the Ministry of Food and Drug Safety, and will launch a clinical t...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.